Navigation Links
Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
Date:6/20/2011

NEW YORK, June 20, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers

http://www.reportlinker.com/p0558483/Global-Nucleic-Acid-Testing-Market--New-Product-Development-Opportunities-and-Business-Expansion-Strategies-For-Instrument-and-Reagent-Suppliers.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.

Highlights

- Business and technological trends in seven major markets

- Five- and ten-year test volume and sales forecasts

- Market shares of leading competitors

- Feature comparison of major analyzers

- Profiles of market players and start-up firms developing innovative technologies and products

- Specific product and business opportunities for instrument and consumable suppliers.

Rationale

The NAT market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next ten years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods.

In order to successfully capitalize on the opportunities presented by the NAT market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next ten years.

Geographic Coverage

- France

- Germany

- Italy

- Japan

- Spain

- UK

- USA

Worldwide Market Overview

- Laboratories performing DNA sequencing and NAT by country and market segment.

- Ten-year test volume and sales projections by country.

Market Segmentation Analysis

- Sales and market shares of major suppliers of NAT reagent kits and components.

- Ten-year test volume and sales forecasts for major applications, including:

- Infectious Diseases - Forensic Testing

- Cancer - Paternity Testing/HLA Typing

- Genetic Diseases - Others

- Ten-year test volume and sales projections for over 30

NAT assays.

- A comprehensive analysis of the sequencing market, by country and laboratory segment, including:

- Industrial - Academic

- Government - Commercial

- Detailed market segmentation analysis, including review of the market dynamics, trends, structure, size,

growth and major suppliers, by country.

Product/Technology Review

- Comparison of leading NAT analyzers from Abbott, Beckman Coulter, BD, Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.

- Extensive review of NAT technologies, test formats, detection methodologies, trends in testing automation and over 30 target/signal amplification methods, including:

- PCR - bDNA

- SDA - NASBA

- TMA - SSSR, and others

- LCR

- Worldwide listings of companies, universities and research centers developing new NAT technologies and products.

Competitive Assessments

- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.

- Comprehensive listings of companies developing and marketing NAT products, by test and application.

Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next ten years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

- Business planning issues and concerns.

Methodology

This report is based on a combination of primary and secondary information sources, including interviews with laboratory directors and executives of leading diagnostic companies and start-up firms developing innovative technologies and products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as Venture Planning Group's proprietary data base was conducted.

Contains 1050 pages and 96 tables

Table of Contents

Introduction

Worldwide Market And Technology Overview

A. DNA Sequencing

1. Introduction

2. Sequencing Methods

3. Autoradiography

4. The Human Genome Project

5. Sequencing Automation

6. Image Scanners

7. Fluorescent Detection

8. Gene Profiling

9. Gene Expression

10. Polymorphism Screening

11. Protein Interaction Networks

B. DNA And RNA Probe Technology

1. Basic Principles

2. Probe Preparation

3. The DNA Probe Test

a. Sample Preparation

b. Hybridization

c. Separation

d. Detection/Measurement

4. Test Formats

a. Filter Hybridization

b. Southern Blot

c. Northern Blot

d. In Situ Hybridization

e. Others

5. Labeling Techniques

6. Amplification Methods

O Polymerase Chain Reaction

- Temperature Cyclers

- PCR Variations

* Immuno-PCR

* QC-PCR

* DAP-PCR

O Strand Displacement Activation

O TMA

O Ligase Chain Reaction

O Branched DNA

- Hybridization Protection Assay

O Nucleic-Acid Sequence-Based Amplification

O Self-Sustained Sequence Replicase

O Others

- Ampliprobe

- CAR

- CAS

- CPT

- Dendritic Polymer Technology

- ISO-CR

- LAT

- Probe Networks

- RAMP

- Repair Chain Reaction

- Rolling Circles

- Sequence Independent Gene Amplification

- Sequence Initiation Reaction

- SISPA

C. Detection Technologies

1. Radioactive Methods

a. Overview

b. Major Isotopes

O P-32

O S-35

O H-3

O I-125

2. Non-Isotopic Methods

a. Enzymatic Labels

b. Chemical Labeling

O Indirect Chemical Labeling

O Direct Chemical Labeling

c. Fluorescence

d. Chemiluminescence

e. Electrical Conductivity

D. Instrumentation Review

1. Abbott LCx

2. Autogenomics Infinity

3. Beckman Coulter/Biomek FK

4. Becton Dickinson SDA

5. Bio-Rad GeneScope

6. Gen-Probe Tigris

7. Nanosphere Verigen Series

8. Roche Cobas Amplicor

9. Tecan LS Series

E. Biochips: Genosensors, Microarrays, and

Labs-on-the-Chip

- Liquid Transportation and Mixing

- Separation

- Reaction

- Detection

F. Pharmacogenomics

G. Major Applications

1. Microbiology/Infectious Diseases

a. Overview

b. Major Infectious Diseases

* AIDS

O Structure and Composition

O Classification

O AIDS Origins

O Animal Lentivirus Systems

O Virus Receptors

O HIV Infections in Humans

- Pathogenesis and Pathology

O CD4T Lymphocytes and Memory Cells

O Monocytes and Macrophages

O Lymphoid Organs

O Neural Cells

O Viral Coinfections

- Clinical Findings

O Plasma Viral Load

O Pediatric AIDS

- Neurologic Disease

- Opportunistic Infections

- Cancer

O Immunity

O Laboratory Diagnosis

- Virus Isolation

- Serology

- Viral Nucleic Acid/Antigen Detection

O Epidemiology

- Worldwide Spread of AIDS

- United States

- Routes of Transmission

O Prevention, Treatment, And Control

- Antiviral Drugs

- Vaccines

O Transmission HIV in Blood Products

O HIV Transmission in Transplant

and Artificial Insemination Recipients

O Diagnostic Tests

- Enzyme Immunoassay Interpretation

- Specificity, Sensitivity and Predictive

Value

O Competition Assays

O Western Blot Technique

O Immuno-Fluorescence Assays (IFA)

O Radioimmunoprecipitation

O HIV-1/HIV-2 Combination Testing

O Methods of HIV-Antigen Detection

O Antigen Assays and Blood Screening

O Urine Tests

O DNA Probes

- Overview

- Quantitative PCR

- In Situ PCR

- Needed Improvements

O Viral Load/Drug Resistance Testing

O Genotype and Phenotype Testing

O Blood Banking Considerations

* Adenovirus

O Background

O Diagnostic Tests

O Vaccines and Drugs

O Adeno-Associated Viruses (AAV)

* Anthrax/Bacillus Anthracis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Babesiosis

O Background

* BEA and Other Bartonella Diseases

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Chagas Disease

O Background

* Campylobacter

O Background

O Diagnostic Tests

- Culture Identification

O Vaccines and Drugs

* Chlamydia

O Background

- Chlamydia psittaci

- Chlmaydia pneumoniae

- Chlamydia trachomatis

O Diagnostic Tests

O Vaccines and Drugs

* Creutzfeldt-Jakob's Disease

O Background

O Blood Transmission

O Diagnostic Tests

O Major Commercial and Academic Players

- Bayer

- Disease Sciences/Bio Tec Global

- Imperial College School of Medicine

- Ortho-Clinical Diagnostics

- Pall

- ProMetic Life Sciences

- Proteome Sciences/Idexx

- Q-One Biotech

- Serono

- U.S. Agricultural Research Service

O Drugs

O Vaccines

* Cytomegalovirus

O Background

- Chorioretinitis

- Gastrointestinal

- Central Nervous System Disease

O Diagnostic Tests

O Vaccines and Drugs

* Ebola Virus

O Background

- Epidemiology

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* EchoVirus

O Background

- Acute Aseptic Meningitisis

- Encephalitis

- Exanthems

- Respiratory Disease

- Myopericarditis

- Neonatal Infections

O Diagnostic Tests

O Vaccines and Drugs

* Encephalitis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Enteroviruses

O Background

O Diagnostic Tests

- Viral Isolation and Identification

- Antibody Tests

O Vaccines and Drugs

* Epstein-Barr Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Gonorrhea

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Hepatitis

O Hepatitis A

O Hepatitis B

- Structure and Composition

- Replication

O Hepatitis C

O Hepatitis D (Delta)

O Hepatitis E

O Hepatitis G

O Hepatitis Infections Pathology

O Clinical Findings

O Laboratory Tests

- Hepatitis A

- Hepatitis B

- Hepatitis C

- Hepatitis D

- Hepatitis E

O Virus-Host Immune Reactions

O Epidemiology

- Hepatitis A

- Hepatitis B

- Hepatitis C

- Hepatitis D (Delta)

O Vaccines and Drugs

* Herpes Simplex Virus

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Legionella

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Lyme Disease

O Background

- Clinical Description

- Clinical Case Definition

- Laboratory Criteria for Diagnosis

- Case Classification

O Diagnostic Tests

O Vaccines and Drugs

* Malaria

* Mycoplasma

O Background

- Ureaplasma Urealyticum & Mycoplasma

Hominis

O Diagnostic Tests

O Vaccines and Drugs

* Papillomaviruses/HPV

O Background

- HPV in Cancer

- Cervical Neoplasm

O Diagnostic Tests

O Vaccines and Drugs

- Prevention

* Parvovirus B19

O Background

- Microbiology

- Epidemiology

- Clinical Syndromes

- Erythema Infectiosum (Slapped Cheek)

- Adult Polyarthropathy

- Transient Aplastic Crisis

- Transient Pancytopenia

- Red Cell Aplasia in Immunocompromised

- Perinatal Infections

O Diagnostic Test

O Vaccines and Drugs

* Pneumonia

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Polyomaviruses

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Salmonellosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Shigellosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Streptococci

O Background

O Diagnostic Tests

O Vaccines and Drugs

- Group A Streptococci

- Group B Streptococci

* Toxoplasmosis

O Background

O Diagnostic Tests

O Vaccines and Drugs

* Tuberculosis

O Background

O Diagnostic Tests

- Microscopic Characteristics

- Cultural Characteristics

- Skin Tests

- MDRTB

O Vaccines and Drugs

* West Nile Virus

O Background

- Clinical Syndromes

O Diagnostic Tests

O Vaccines and Drugs

* Yersinia

O Background

O Diagnostic Tests

O Vaccines and Drugs

c. Antibiotic Susceptibility

2. Cancer Testing

a. Overview

b. Major Cancer Types

* Prostate

* Lung

* Colon and Rectum

* Breast

* Skin

* Uterine

* Leukemia

* Oral

c. Oncogenes

O Abl/abl-bcr

O AIB1

O BRCA1

O CD44

O C-fos

O C-myb

O C-myc

O CYP17

O Erb-B

O HPC1

O N-myc

O P40

O P51

O P53

O PIK3CA

O PTI-1

O Ras

O Reg

O Sis

O Src

3. Genetic Diseases

a. Overview

b. Nucleic Acid Amplification

c. Chromosome Imaging

d. Genomics Technologies

e. Proteomics Technologies

f. Current Pharmacogenomic Tests

g. Future Pharmacogenomic Testing

h. Major Diseases

* Achondroplasia

* Autosomal Dominant Polycystic Kidney

Disease

* Cancer

* Cosmetogenomics

* Cystic Fibrosis

* Down's Syndrome

* Duchenne and Becker Muscular Dystrophy

* Factor V (Leiden)

* Factor IX Deficiency

* Fragile X Syndrome

* Heart Disease

* Hemochomatosis

* Hemophilia

* Huntington's Disease

* Maternal-Fetal Incompatibility

* Multiple Endocrine Neoplasia

* Phenylketonuria (PKU)

* Polycystic Kidney Disease (PKD)

* Prenatal Screening

* Retinitis Pigmentosa

* Retinoblastoma

* Sickle Cell Anemia

* Spinal Muscular Atrophy

* Vitamin B12 Metabolism

i. Social Issues and Concerns

4. Forensic Testing

a. Overview

b. Multilocus and Single Locus Probes

* Multilocus Probes

* Single Locus Probes

* PCR and RFLP

c. The FBI

d. DNA Profile Data Banks

* U.S.A.

* U.K.

e. Judicial Implementation

f. Major Crime Categories

g. Factors Contributing to the DNA Probe

Market Expansion

* Technology Availability

* Use of Hair as Evidence

h. Wildlife Forensics

5. Paternity Testing/HLA Typing

6. Other Applications

a. Disease Susceptibility Testing

b. Cardiovascular Diseases

c. Diabetes

d. Alzheimer's Disease

e. Plasma Purification

f. Organ Transplantation

g. Water Contamination

h. Others

G. Cost Analysis

1. Equipment

2. Consumables

H. Competing/complementing Technologies

1. Monoclonal Antibodies/Immunoassays

2. RNA Probes

3. Two-Dimensional Electrophoresis

4. Flow Cytometry

I. Reimbursement Issues

J. Worldwide Market Overview

1. Business Environment

2. Market Structure

3. Market Size and Growth

France

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth And Major Suppliers'

Sales And Market Shares

Germany

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth And Major Suppliers'

Sales And Market Shares

Italy

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth And Major Suppliers'

Sales And Market Shares

Japan

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth And Major Suppliers'

Sales And Market Shares

Spain

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth And Major Suppliers'

Sales And Market Shares

U.K.

A. Executive Summary

B. Business Environment

C. Market Structure

D. Market Size, Growth And Major Suppliers'

Sales And Market Shares

U.S.A.

A. Executive Summary

B. Business Environment

1. Health Care Expenditures

2. Cost Consciousness

3. Reimbursement

4. Industry Consolidation

5. Managed Care

a. HMO

b. PPO

6. Hospitals

7. Admissions

8. Length of Stay

9. Industry Diversification

10. Physician Demographics

11. Population Aging

a. Chronic Illness

b. Disease Incidence

c. Susceptibility to Iatrogenesis

d. Multiple Illness Cases

12. Laboratory Regulations

13. FDA Reform

C. Market Structure

1. Hospitals

2. Commercial/Private Laboratories

3. Blood Banks

D. Market Size, Growth and Major Suppliers'

Sales and Market Shares

Major Product Development Opportunities

A. Instrumentation

B. Reagent Kits and Test Systems/panels

C. Computers, Software and Automation

D. Auxiliary Products

Design Criteria For Decentralized Testing Products

Alternative Market Penetration Strategies

A. Internal Development

B. Collaborative Arrangements

C. University Contracts

D. Distribution Strategies For Decentralized Testing

Markets

1. Marketing Approaches

2. Product Complexity

3. Customer Preference

4. Established Suppliers

5. Emerging Suppliers

6. Major Types Of Distributors

7. Market Segmentation

Potential Market Entry Barriers And Risks

A. Market Maturity

B. Cost Containment

C. Competition

D. Technological Edge And Limitations

E. Patent Protection

F. Regulatory Constraints

G. Decentralized Testing Market Challenges

Competitive Profiles

- Abbott

- Aclara

- Affymetrix

- Agilent

- Ambion

- Applera

- Applied Gene Technologies

- Beckman Coulter

- Becton Dickinson

- Biokit

- BioMerieux

- Biotest

- Boston Biomedica

- Caliper

- Cepheid

- Chiron

- Decode

- Diadexus

- Digene

- Eiken

- Enzo

- Exact Sciences

- Fujirebio

- Gen-Probe

- Gene Tec

- Illumina

- Innogenetics

- Kreatech

- Li-Cor

- Molecular Diagnostics

- Myriad Genetics

- Nanogen

- Nuvelo

- Orchid Biosciences

- Qiagen

- Roche

- Sangtec

- Sequenom

- Scienion

- Sierra Diagnostics

- Shimadzu

- Takara Bio

- Tepnel Life Sciences

- Tecan Group

- Third Wave

Appendixes

Appendix I: Major Companies Developing or Marketing

NAT Reagents and Test Kits

Appendix II: Major Universities and Research Centers

Developing NAT Technologies

Appendix III: Glossary of Terms

Appendix IV: Currency Exchange Rates

List of Tables

Major Companies Developing or Marketing Thermocyclers

Major Companies Developing or Marketing AIDS NAT

And Other Direct Identification Tests

Major Companies Developing or Marketing Adenovirus

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Campylobacter

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Chlamydia

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing CMV NAT

And Other Direct Identification Tests

Major Companies Developing or Marketing EBV NAT

And Other Direct Identification Tests

Major Companies Developing or Marketing Gonorrhea

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Hepatitis

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Herpes

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Legionella

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Lyme

Disease NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Mycoplasma

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Papilloma

Virus NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Pneumonia

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Salmonella

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Shigella

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Streptococci

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Toxoplasmosis

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Tuberculosis

NAT And Other Direct Identification Tests

Major Companies Developing or Marketing Cancer

NAT Tests

Major Companies Developing or Marketing NAT Assays

For Genetic Diseases

Worldwide, Laboratories Performing DNA Sequencing

By Country

Worldwide, NAT Market, Potential Laboratory Universe by Country

Worldwide, NAT Volume Forecast by Country

Worldwide, NAT Market Forecast by Country

Summary Table France, NAT Volume And Sales Forecast

by Major Application

France, Laboratories Performing DNA Sequencing

By Market Segment

France, NAT Market Potential

Laboratory Universe by Market Segment

France, NAT Volume Forecast By Major Application

France, Major Infectious Disease NAT Volume Forecast

France, Infectious Disease Screening

NAT Volume Forecast

France, NAT Market Forecast By Major Application

France, Infectious Disease Screening NAT Reagent

Market Forecast by Test

France, NAT Market By Major Supplier

France, HIV/Hepatitis NAT Market By Major Supplier

Summary Table Germany, NAT Volume

And Sales Forecast by Major Application

Germany, Laboratories Performing

DNA Sequencing by Market Segment

Germany, NAT Market Potential Laboratory Universe

By Market Segment

Germany, NAT Volume Forecast By Major Application

Germany, Major Infectious Disease NAT Volume Forecast

Germany, Infectious Disease Screening

NAT Volume Forecast

Germany, NAT Market Forecast By Major Application

Germany, Infectious Disease Screening

NAT Reagent Market Forecast by Test

Germany, NAT Market by Major Supplier

Germany, HIV/Hepatitis NAT Market by Major Supplier

Summary Table Italy, NAT Volume

And Sales Forecast by Major Application

Italy, Laboratories Performing

DNA Sequencing by Market Segment

Italy, NAT Market Potential

Laboratory Universe by Market Segment

Italy, NAT Volume Forecast By Major Application

Italy, Major Infectious Disease NAT Volume Forecast

Italy, Infectious Disease Screening

NAT Volume Forecast

Italy, NAT Market Forecast By Major Application

Italy, Infectious Disease Screening

NAT Reagent Market Forecast by Test

Italy, NAT Market By Major Supplier

Italy, HIV/Hepatitis NAT Market

By Major Supplier

Summary Table Japan, NAT Volume

And Sales Forecast by Major Application

Japan, Laboratories Performing

DNA Sequencing by Market Segment

Japan, NAT Market Potential

Laboratory Universe by Market Segment

Japan, NAT Volume Forecast By Major Application

Japan, Major Infectious Disease NAT Volume Forecast

Japan, Infectious Disease Screening

NAT Volume Forecast

Japan, NAT Market Forecast By Major Application

Japan, Infectious Disease Screening NAT

Market Forecast by Test

Japan, NAT Market By Major Supplier

Japan, HIV/Hepatitis NAT Market by Major Supplier

Summary Table Spain, NAT Volume

And Sales Forecast by Major Application

Spain, Laboratories Performing

DNA Sequencing by Market Segment

Spain, NAT Market, Potential

Laboratory Universe by Market Segment

Spain, NAT Volume Forecast by Major Application

Spain, Major Infectious Disease NAT Volume Forecast

Spain, Infectious Disease Screening

NAT Volume Forecast

Spain, NAT Market Forecast By Major Application

Spain, Infectious Disease Screening NAT

Reagent Market Forecast by Test

Spain, NAT Market By Major Supplier

Spain, HIV/Hepatitis NAT Market by Major Supplier

Summary Table U.K., NAT Volume

And Sales Forecast by Major Application

U.K., Laboratories Performing

DNA Sequencing by Market Segment

U.K., NAT Market Potential

Laboratory Universe by Market Segment

U.K., NAT Volume Forecast By Major Application

U.K., Major Infectious Disease NAT Volume Forecast

U.K., Infectious Disease Screening

NAT Volume Forecast

U.K., NAT Market Forecast By Major Application

U.K., Infectious Disease Screening NAT Reagent

Market Forecast by Test

U.K., NAT Market by Major Supplier

Summary Table U.S.A., NAT Volume

And Sales Forecast by Major Application

U.S.A., Laboratories Performing

DNA Sequencing by Market Segment

U.S.A., NAT Market, Potential

Laboratory Universe by Market Segment

U.S.A., NAT Volume Forecast By Major Application

U.S.A., Major Infectious Disease NAT Volume Forecast

U.S.A., Infectious Disease Screening

NAT Volume by Test Forecast

U.S.A., NAT Market Forecast By Major Application

U.S.A., Infectious Disease Screening NAT Reagent

Market Forecast by Test

U.S.A., NAT Market by Major Supplier

U.S.A., HIV/Hepatitis C NAT Market By Major Supplier

U.S.A., West Nile Virus NAT Market By Major Supplier

To order this report:

Pathology Industry: Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers

Pathology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

__________________________

Contact Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... new report "Global Anti-Bacterial Drugs Market Assessment & Forecast: 2015 - ... the North America continued to lead global ... translated into revenues worth US$ 16,907.3 million. ... Asia-Pacific , Latin America , ... anti-bacterial market is inclined towards North America ...
(Date:2/8/2016)... -- Respiratory Devices - Medical Devices Pipeline Assessment, ... report, " Respiratory Devices - Medical Devices Pipeline ... Devices currently in pipeline stage. The report ... comparative analysis of the products at various stages ... in the pipeline product development. It also provides ...
(Date:2/8/2016)... and FAIRFIELD, N.J. , Feb. 8, ... Pharmaceuticals, Inc. (Medimetriks) today announced that they have entered ... commercialization rights for OPA-15406 in the U.S. and ... manufacturing rights.  OPA-15406 is a topical, non-steroidal phosphodiesterase IV ... --> --> In ...
Breaking Medicine Technology:
(Date:2/9/2016)... (PRWEB) , ... February 09, 2016 , ... ... Techniques.” The guide will ensure lab personnel have a basic understanding of the ... lab measurement protocols. Enhanced understanding will help them reduce waste and rework to ...
(Date:2/9/2016)... California (PRWEB) , ... February 09, 2016 , ... i2i ... one of the highest preliminary data vendors in the latest KLAS report, Population Health ... i2i has led the developing market for population health management (PHM). The latest ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... with BASF Human Nutrition into the Food & Beverage and ... been BASF’s channel partner throughout Canada and USA geographies east of the Rocky ...
(Date:2/8/2016)... ... February 08, 2016 , ... Brenton Engineering , powered ... and flow wrapped products at WestPack 2015, February 9-11, in Anaheim, California. This ... to semi-automatic or fully-automatic case packing with a small footprint, rugged, highly flexible, ...
(Date:2/8/2016)... ... 08, 2016 , ... Local insurance agency Dennis Fuller & ... has initiated a fundraiser for a two year old little girl named Bella, ... To support this beautiful child who is facing life’s journey without her loving ...
Breaking Medicine News(10 mins):